To combat returns, Zalando's AI analyzes a user's photos, purchase history, and data from similar customers to predict the correct size for a new item. The ultimate goal is to become so confident in its predictions that for some products, the user won't even need to select a size at all.

Stitch Fix addresses overwhelming consumer choice with "Stitch Fix Vision," an AI tool generating images of customers in shoppable outfits. This transforms shopping from a chore of endless scrolling into a fun, personalized experience that increases customer engagement and satisfaction.

Competing on a prescription drug like a GLP-1 is difficult. The real opportunity for entrepreneurs is in the surrounding ecosystem. This includes selling supplements to counteract muscle loss, providing nutritional counseling, and creating lifestyle management programs for patients using these drugs.

Facing intense competition from online-only brands, Victoria's Secret is leveraging its retail footprint. By implementing smart dressing rooms with RFID tags and digital screens for requesting new sizes, it solves a major online shopping pain point, turning a legacy physical asset into a key differentiator and driver of sales.

Research shows that while GLP-1 drug users eat less, they will pay more for high-quality ingredients. This creates a strategic opportunity for restaurants to increase profit margins by offering smaller, premium-priced dishes, tapping into the retail psychology that smaller items can carry a higher proportional markup.

Weight-loss drugs like Ozempic have moved from a niche medical treatment to a mainstream phenomenon, with new data showing 15.2% of all American women are now taking them. This rapid, large-scale adoption signifies a major public health shift that will have downstream effects on the food, fitness, and healthcare industries.

The widespread adoption of GLP-1 therapies is projected to decrease total U.S. calorie consumption by 1.6% by 2035. This second-order effect will create significant disruption and headwinds for industries reliant on consumer food purchasing, including the CPG, retail, and restaurant sectors.

A major problem with GLP-1 drugs is that users often regain weight after stopping because they haven't learned new habits. Nutrisense addresses this by providing data and coaching to build sustainable lifestyle changes, making it a complementary, long-term solution.

AI enables the creation of "personal software" for unique problems. An example is an app that takes a photo of a clothing size chart, compares it against pre-loaded body measurements, and recommends the optimal size, solving a persistent e-commerce issue for an audience of one.